Bristol Myers Squibb (BMY) Raw Materials (2010 - 2013)

Bristol Myers Squibb has disclosed Raw Materials across 4 years of filings, most recently posting $338.0 million for Q1 2013.

• In Q1 2013, Raw Materials rose 40.25% year-over-year to $338.0 million; the TTM figure through Mar 2013 stood at $338.0 million (up 40.25% YoY), while the FY2012 annual figure was $271.0 million, up 4.23% from the prior year.
• Raw Materials improved to $338.0 million in Q1 2013, from $271.0 million in the prior quarter.
• Over the last five years, Raw Materials for BMY reached as high as $357.0 million in Q2 2011 and fell as low as $199.0 million in Q4 2010.
• The 4-year median for Raw Materials is $261.5 million (2011), against an average of $264.8 million.
• The widest YoY moves for Raw Materials: up 44.39% in 2012, down 26.33% in 2012.
• A 4-year view of Raw Materials shows it stood at $199.0 million in 2010, then soared by 30.65% to $260.0 million in 2011, then advanced by 4.23% to $271.0 million in 2012, then gained by 24.72% to $338.0 million in 2013.
• According to Business Quant data, Raw Materials over the past three periods registered $338.0 million, $271.0 million, and $296.0 million for Q1 2013, Q4 2012, and Q3 2012 respectively.